*Result*: Clinical efficacy of SARS‐CoV‐2 Omicron‐neutralizing antibodies in immunoglobulin preparations for the treatment of agammaglobulinemia in patients with primary antibody deficiency
*Author/editor-in-chief*:
*Publication*:
Freiburg : Universität, 2025
*Physical description scale*:
1 Online-Ressource
*Format*:
*Language*:
*eng*
*Notes*:
Journal of medical virology. - 96, 6 (2024) , e29738, ISSN: 1096-9071
*DOI*:
10.1002/jmv.29738